University of North Carolina at Chapel Hill

Grantee website Chapel Hill, North Carolina, United States
Purpose
to conduct Phase III trials and obtain regulatory approval for an oral drug for early stage African sleeping sickness
Grantee
Division
Global Health
Date
APRIL 2006
Region served
AFRICA
Committed amount
$16,786,971
Grant topic
Neglected Tropical Diseases
Duration (months)
98
Grantee location
Chapel Hill, North Carolina, United States
Related work

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.